Prosthetic Complications of Screw Retained Restoration

NCT ID: NCT03674554

Last Updated: 2018-09-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-01

Study Completion Date

2020-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

On of the main fixed prosthetic options of completely edentulous patients is the screw-retained implant supported prosthesis which was constructed on transmucosal abutments with its encountered problems such as: hardness to make it passively seated with multiple screw fracture and loosening problems and multiple encountered veneer material fracture and so there effect on patient satisfaction with multiple maintenance recalls.so, the investigators want to try a new technique of fabrication which was proposed for reducing the problems of lack of passivity which is the intraoral luting cement technique on titanium bases with reduced screw number but, with luting cement problems as de-cementation and cement biological effects on soft tissues and bone and there effect on number of patient recall visits and maintenance and so there effect on patient satisfaction

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Edentulous Jaw Edentulous Alveolar Ridge Edentulous Mouth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Allocation sequence generation will be performed by the Senior supervisor. Enrolment of participants will be performed by the principle investigator where the patients will be assessed for eligibility.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

titanium bases group

full-arch screw-retained implant prosthesis on titanium bases using intra oral luting cement technique

Group Type EXPERIMENTAL

titanium bases using intra oral luting cement technique

Intervention Type PROCEDURE

a full-arch screw-retained implant prosthesis on titanium bases using intra oral luting cement technique

transmucosal abutment group

a full-arch screw-retained implant prosthesis with transmucosal abutment

Group Type EXPERIMENTAL

transmucosal abutment

Intervention Type PROCEDURE

a full-arch screw-retained implant prosthesis with transmucosal abutment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

titanium bases using intra oral luting cement technique

a full-arch screw-retained implant prosthesis on titanium bases using intra oral luting cement technique

Intervention Type PROCEDURE

transmucosal abutment

a full-arch screw-retained implant prosthesis with transmucosal abutment

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \- Completely edentulous patients
* Patients with completely edentulous ridges have an opposing natural dentition or implant supported overdenture
* Completely edentulous patients (with the above mentioned criteria) who have proper amount of attached gingiva (≥2 mm) or to be created
* Completely edentulous patients (with the above mentioned criteria) who have no history of bruxism
* Completely edentulous patients (with the above mentioned criteria) who were free or controlled diabetic assessed by measuring glycosylated haemoglobin (HbA1c). (lesser than or equal to 6.4 percent )

Exclusion Criteria

* \- Patients having a medical condition that absolutely contraindicates implant placement.
* Patients with uncontrolled diabetes, assessed by measuring glycosylated haemoglobin (HbA1c). (greater than to 6.4 percent )
* Potentially uncooperative patients who are not willing to go through the proposed interventions. - Moderate-to-heavy daily smokers\* (who report consuming at least 11 cigarettes/day).
* Patients who are having complete lower denture
* Patients who have history of bruxism
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

mostafa said hosny

Assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo Universty

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

mostafa said hosny, M.Sc. 2018

Role: CONTACT

0100779234 ext. 002

Amr hosny elkadem, phd

Role: CONTACT

01001162401 ext. 002

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

mostafa said hosny, M.Sc. 2018

Role: primary

01007799234 ext. 002

amr hosny elkhadem, phd

Role: backup

01001162401 ext. 002

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

28809010109913

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.